Abstract
Genetic amplification at chromosome 8p23.1 has been reported in some solid tumors. Translocation of 8p23.1 has also been reported in hematological malignancies and head and neck squamous cell cancer. In an attempt to clarify whether this translocation is implicated in lymphomagenesis, we performed FISH analysis of the immunoblastic B-cell lymphoma cell line OCI-LY8, which has chromosome translocation at 8p23.1, with various BAC clones. We found split signals on BAC, RP11-18L2 where the MASL1 gene is located. This translocation was found to produce a chimeric transcript of MASL1 exon 1 with a cryptic exon from the genome region at 14q21. Our study indicates that MASL1 is not only a target gene for genomic amplification but also for chromosomal translocation. Since tumorigenic activity of the MASL1 has not been proven, its in vitro transforming activity was studied and in vivo nude mice assay were performed. Although no in vitro transforming activity was detected by focus formation, the in vivo tumorigenesis assay with nude mice showed that both MASL1 and chimeric MASL1 possess tumorigenic activity. This suggests that MASL1 is an important oncogene not only for solid tumors but also for hematologic malignancies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chaganti SR, Rao PH, Chen W, Dyomin V, Jhanwar SC, Parsa NZ, Dalla-Favera R and Chaganti RSK . (1998). Genes Chromosomes Cancer, 23, 328–336.
Chang H, Messner HA, Wang XH, Yee C, Addy I, Meharchand J and Minden MD . (1995). J. Clin. Invest., 89, 1014–1020.
Emi M, Fujiwara Y, Nakamura T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta Y, Miyaki M and Nakamura Y . (1992). Cancer Res., 52, 5368–5372.
Gilhuis HJ, Anderl KL, Boerman RH, Jeuken JM, James CD, Raffel C, Scheithauer BW and Jenkins RB . (2000). Clin. Neurol. Neurosurg., 102, 203–209.
Jin Y, Jin C, Wennerberg J, Hoglund M and Mertens F . (2001). Cancer Genet. Cytogenet., 15, 111–117.
Knowles MA, Shaw ME and Proctor AJ . (1993). Oncogene, 8, 1357–1529.
Komatsu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahashi Y, Ueda R and Seto M . (1994). Blood, 84, 1226–1231.
Martinez-Climent JA, Vizcarra E, Sanchez D, Blesa D, Marugan I, Benet I, Sole F, Rubio-Moscardo F, Terol MJ, Climent J, Sarsotti E, Tormo M, Andreu E, Salido M, Ruiz MA, Prosper F, Siebert R, Dyer MJ and Garcia-Conde J . (2001). Blood, 98, 3479–3482.
Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P and Bergerheim US . (1994). Oncogene, 9, 3071–3076.
Mehra S, Messner H, Minden M and Chaganti RSK . (2002). Genes Chromosome Cancer, 33, 225–234.
Nupponen NN and Visakorpi T . (2000). Microsc. Res. Tech., 51, 456–463.
Pykett MJ, Murphy ME, Harnish PR, Muenke M, Markes J and George DL . (1994). Cancer Genet. Cytogenet., 76, 23–28.
Sakabe T, Shinomiya T, Mori T, Ariyama Y, Fujiwara T, Nakamura Y and Inazawa J . (1999). Cancer Res., 59, 511–515.
Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T and Inazawa J . (1999). Genes Chromosomes Cancer, 24, 299–305.
Seto M, Yamamoto K, Iida S, Akao Y, Utsumi K, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M, Motokura T, Arnold A, Takahashi T and Ueda R . (1992). Oncogene, 7, 1401–1406.
Sin C, Shilo BZ, Golofarb MP, Dannenberg A and Weinberg RA . (1979). Proc. Natl. Acad. Sci. USA, 76, 5714–5718.
Stock C, Kager L, Fink FM, Gadner H and Ambros PF . (2000). Genes Chromosomes Cancer, 28, 329–333.
Sunwoo JB, Holt MS, Radford DM and Scholnick SB . (1996). Genes Chromosomes Cancer, 13, 168–174.
Tagawa H, Miura I, Suzuki R, Suzuki H, Hosokawa Y and Seto M . (2002). Genes Chromosomes Cancer, 34, 175–185.
Tanner MM, Karhu RA, Nupponen NN, Borg A, Baldetorp B, Pejovic T, Ferno M, Killander D and Isola JJ . (1998). Am. J. Pathol., 153, 191–199.
Tweeddale ME, Lim B, Jamal N, Robinson J, Zalcberg J, Lockwood G, Minden MD and Messner HA . (1987). Blood, 69, 1307–1314.
Wong N, Wang KF, Chan JKC and Johnson PJ . (2000). Hum. Pathol., 31, 771–774.
Acknowledgements
This work was supported in part by a Grant-in-aid for the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health and Welfare Japan; a Grant-in-aid for Science on Primary Areas (Cancer Research); and a Grant-in-aid for Encouragement of Young Scientists from the Ministry of Education, Science and Culture, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tagawa, H., Karnan, S., Kasugai, Y. et al. MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8. Oncogene 23, 2576–2581 (2004). https://doi.org/10.1038/sj.onc.1207352
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207352
Keywords
This article is cited by
-
High Glucose Stimulates Expression of MFHAS1 to Mitigate Inflammation via Akt/HO-1 Pathway in Human Umbilical Vein Endothelial Cells
Inflammation (2018)
-
Role and mechanism of action of leucine-rich repeat kinase 1 in bone
Bone Research (2017)
-
Ubiquitylation of MFHAS1 by the ubiquitin ligase praja2 promotes M1 macrophage polarization by activating JNK and p38 pathways
Cell Death & Disease (2017)
-
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
Leukemia (2010)